EBAMed

Geneva, Switzerland

EBAMed develops innovative solutions for non-invasive and automated treatment of heart arrhythmias by using ion beams.

$1.7M raised

Jan 2025

Series A

Top Investors

CDP Venture CapitalPanakes PartnersMayo ClinicEuropean Innovation CouncilMassChallenge

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has EBAMed raised?

EBAMed has raised $1.7M in total funding. The most recent round was Series A. The last funding was announced in January 2025.

Who are EBAMed's investors?

EBAMed's investors include CDP Venture Capital, Panakes Partners, Mayo Clinic, European Innovation Council, MassChallenge.

Where is EBAMed headquartered?

EBAMed is headquartered in Geneva, Switzerland.

What does EBAMed do?

EBAMed develops innovative solutions for non-invasive and automated treatment of heart arrhythmias by using ion beams.

What stage is EBAMed at?

EBAMed is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 21, 2025.

MLA

"EBAMed — Funding & Investors." VCBacked, January 21, 2025, https://www.vcbacked.co/company/ebamed. Accessed June 4, 2026.

APA

VCBacked. (2025). EBAMed — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ebamed

Wikipedia (cite web)

{{cite web |title=EBAMed — Funding & Investors |url=https://www.vcbacked.co/company/ebamed |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 21, 2025.